These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15698944)

  • 1. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis.
    Ionescu AA; Nixon LS; Shale DJ
    J Cyst Fibros; 2004 Dec; 3(4):253-8. PubMed ID: 15698944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.
    Bolton CE; Broekhuizen R; Ionescu AA; Nixon LS; Wouters EF; Shale DJ; Schols AM
    Thorax; 2007 Feb; 62(2):109-14. PubMed ID: 16928709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis.
    Ionescu AA; Nixon LS; Luzio S; Lewis-Jenkins V; Evans WD; Stone MD; Owens DR; Routledge PA; Shale DJ
    Am J Respir Crit Care Med; 2002 Feb; 165(4):495-500. PubMed ID: 11850342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
    Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
    Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density, body composition, and inflammatory status in cystic fibrosis.
    Ionescu AA; Nixon LS; Evans WD; Stone MD; Lewis-Jenkins V; Chatham K; Shale DJ
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):789-94. PubMed ID: 10988084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis.
    Enright S; Chatham K; Ionescu AA; Unnithan VB; Shale DJ
    J Cyst Fibros; 2007 Nov; 6(6):384-90. PubMed ID: 17400035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition assessment in adults with cystic fibrosis: comparison of dual-energy X-ray absorptiometry with skinfolds and bioelectrical impedance analysis.
    King S; Wilson J; Kotsimbos T; Bailey M; Nyulasi I
    Nutrition; 2005; 21(11-12):1087-94. PubMed ID: 16183254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
    Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
    Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of fat-free mass over four years in adult cystic fibrosis is associated with high serum interleukin-6 levels but not tumour necrosis factor-alpha.
    King SJ; Nyulasi IB; Bailey M; Kotsimbos T; Wilson JW
    Clin Nutr; 2014 Feb; 33(1):150-5. PubMed ID: 23664115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis.
    Dufresne V; Knoop C; Van Muylem A; Malfroot A; Lamotte M; Opdekamp C; Deboeck G; Cassart M; Stallenberg B; Casimir G; Duchateau J; Estenne M
    Am J Respir Crit Care Med; 2009 Jul; 180(2):153-8. PubMed ID: 19342416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of body composition and lung function in children with cystic fibrosis.
    Pedreira CC; Robert RG; Dalton V; Oliver MR; Carlin JB; Robinson P; Cameron FJ
    Pediatr Pulmonol; 2005 Mar; 39(3):276-80. PubMed ID: 15668934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index.
    King SJ; Nyulasi IB; Strauss BJ; Kotsimbos T; Bailey M; Wilson JW
    Nutrition; 2010; 26(7-8):753-9. PubMed ID: 19931415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and pulmonary function in the elderly: a 7-year longitudinal study.
    Rossi A; Fantin F; Di Francesco V; Guariento S; Giuliano K; Fontana G; Micciolo R; Solerte SB; Bosello O; Zamboni M
    Int J Obes (Lond); 2008 Sep; 32(9):1423-30. PubMed ID: 18645577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
    Groenewegen KH; Dentener MA; Wouters EF
    Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.